Thyia: The comfortable and convenient solution to the smear.
Thyia: The comfortable and convenient solution to the smear.
批准号:
10071373
负责人:
金额:
$41.09万
依托单位:
依托单位国家:
英国
项目类别:
Collaborative R&D
财政年份:
2023
资助国家:
英国
项目状态:
未结题
起止时间:
2023 至 --
中文摘要
在英国,每天有9名女性被诊断出患有宫颈癌。也就是说,有9位女性、母亲、女儿、妻子、女朋友和朋友的生活受到了这种疾病的影响。好消息是,99%的子宫颈癌是可以通过简单的子宫颈癌筛查来预防的。然而,三分之一的妇女没有参加子宫颈普查计划,导致20年来宫颈癌发病率最高,特别是年轻妇女、少数族裔和来自弱势背景的妇女。这就是我们创建Thyia的原因,这是一个远程医疗平台,旨在增强妇女的医疗保健能力,终结宫颈癌。有了Thyia,女性可以在舒适的家中,以方便、舒适和个人的体验控制自己的宫颈健康。我们的平台提供了一些具体和创新的功能,包括用于患者主导的临床决策支持的人工智能聊天机器人、指导指南、与全科医生和NHS子宫颈筛查管理系统共享结果的集成、后续转介、临床医生视频咨询以及关于宫颈癌、HPV、自我检测和疫苗接种的教育。我们的平台由ukca认证的棉签支持,所以女性可以自己测试。该棉签使用实验室PCR技术,类似于用于Covid-19检测的技术,临床证明与传统棉签具有相同的灵敏度。自1964年在英国引入涂片检查以来,涂片检查一直没有改变,由于这种停滞不前,宫颈癌的发病率达到了20年来的最高水平。在Thyia,我们热衷于通过结合新技术,严格的临床数据和出色的患者支持来重新设计过时和服务不足的女性健康领域来改变这种状况。没有马镫,没有窥镜,只有你。在一起,我们可以有所作为,让宫颈癌成为过去。
英文摘要
Every day, nine women in the UK are diagnosed with cervical cancer. That is nine women, mothers, daughters, wives, girlfriends, and friends whose lives are impacted by this disease.The good news is that 99% of cervical cancers are preventable with simple cervical cancer screening. However, one in three women doesn't attend the cervical screening programme, leading to the highest cervical cancer rates in 20 years, especially for young women, minority ethnic groups, and those from disadvantaged backgrounds. That's why we're creating Thyia, a telehealth platform designed to empower women's healthcare and put an end to cervical cancer. With Thyia, women can take control of their cervical health from the comfort of their own homes, with a convenient, comfortable, and personal experience.Our platform offers several specific and innovative features, including an AI chatbot for patient-led clinical decision support, instruction guides, integrations for sharing results with GPs and the NHS Cervical Screening Management System, referrals for follow-up, clinician video consultations, and education about cervical cancer, HPV, self-testing and vaccination. Our platform is supported by a UKCA-certified swab so women can test themselves. The swab uses laboratory PCR technology, similar to that used for Covid-19 testing, and is clinically proven to have equal sensitivity to a traditional swab.The smear test hasn't changed since it was introduced in the UK in 1964, and cervical cancer rates are at a 20-year high because of this stagnation. At Thyia, we are passionate about changing this by combining novel technology, rigorous clinical data, and excellent patient support to redesign an outdated and underserved area of women's health. No more stirrups, no more speculums, no one but you. Together, we can make a difference and make cervical cancer a thing of the past.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金